Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Insights

Ann Latner Headshot
Commentary
David vs Goliath: PBM Tries to Force Independent Pharmacy into Arbitration
03/21/2024
Ann Latner, JD
Caremark has moved to compel Osterhaus into arbitration, citing a mandatory arbitration clause in their Provider Manual, which Osterhaus opposes, arguing the clause is unfair as Caremark's contracts are non-negotiable, placing burdensome...
Caremark has moved to compel Osterhaus into arbitration, citing a mandatory arbitration clause in their Provider Manual, which Osterhaus opposes, arguing the clause is unfair as Caremark's contracts are non-negotiable, placing burdensome...
Caremark has moved to compel...
03/21/2024
Pharmacy Learning Network
Commentary
Overcoming Barriers for Opioid Use Disorder Treatment and Drug Overdoses: Moving Forward
03/14/2024
Yvette C Terrie, BS Pharm, RPh, consultant pharmacist
The opioid epidemic remains a critical public health concern, with various stakeholders striving to combat its challenges, including stigma, access to treatment, and rising overdose rates. Recent FDA approvals have made naloxone available...
The opioid epidemic remains a critical public health concern, with various stakeholders striving to combat its challenges, including stigma, access to treatment, and rising overdose rates. Recent FDA approvals have made naloxone available...
The opioid epidemic remains a...
03/14/2024
Pharmacy Learning Network

Advertisement

Ann Latner
Commentary
VA Pharmacy Tech Gets Prison Time for Stealing Veterans’ Meds
03/14/2024
Ann Latner, JD
A pharmacy technician working at the Veteran’s Affairs Medical Center in Kerrville, Texas, has been sentenced to prison for his role in a scheme to steal narcotic medications from US veterans and sell them illegally for profit.
A pharmacy technician working at the Veteran’s Affairs Medical Center in Kerrville, Texas, has been sentenced to prison for his role in a scheme to steal narcotic medications from US veterans and sell them illegally for profit.
A pharmacy technician working at...
03/14/2024
Pharmacy Learning Network
Douglass Jennings
Talking Therapeutics
A New Standard for Calcium Replacement in Pregnancy
03/14/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this installment of Talking Therapeutics, Dr Jennings explores a new study that evaluated a simplified calcium administration plan to prevent hypertensive-related pregnancy complications.
In this installment of Talking Therapeutics, Dr Jennings explores a new study that evaluated a simplified calcium administration plan to prevent hypertensive-related pregnancy complications.
In this installment of Talking...
03/14/2024
Pharmacy Learning Network
Douglass Jennings
Talking Therapeutics
Confirmed Risks for MI and CVA With Triptan Therapy
03/12/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this installment of Talking Therapeutics, Dr Jennings reviews triptans and their impact on myocardial infarction and cerebrovascular accidents.
In this installment of Talking Therapeutics, Dr Jennings reviews triptans and their impact on myocardial infarction and cerebrovascular accidents.
In this installment of Talking...
03/12/2024
Pharmacy Learning Network

Advertisement

Commentary
Exploring Drug Use Among Adolescents: Contributing Factors and Proposed Prevention Strategies
03/08/2024
Yvette C Terrie, BS Pharm, RPh, consultant pharmacist
The CDC indicates that substance abuse, including opioid use disorder (OUD), often begins during adolescence and increases the probability of continued substance use disorders (SUD) and drug overdoses in adulthood.
The CDC indicates that substance abuse, including opioid use disorder (OUD), often begins during adolescence and increases the probability of continued substance use disorders (SUD) and drug overdoses in adulthood.
The CDC indicates that substance...
03/08/2024
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Kentucky Attorney General Sues Kroger Pharmacies Over Opioid Crisis
03/08/2024
Ann Latner, JD
“Defendants, not the taxpayers of Kentucky, should pay for their role in creating and fueling the opioid epidemic and act to remediate the crisis," said Kentucky Attorney General Russell Coleman.
“Defendants, not the taxpayers of Kentucky, should pay for their role in creating and fueling the opioid epidemic and act to remediate the crisis," said Kentucky Attorney General Russell Coleman.
“Defendants, not the taxpayers...
03/08/2024
Pharmacy Learning Network
Ann Latner, Headshot
Commentary
California’s ‘Stop Dangerous Pharmacies’ Act
03/07/2024
Ann Latner, JD
California Assembly Bill 1286, the Stop Dangerous Pharmacist Act, was passed in late 2023 and took effect at the start of this year. The bill makes some significant changes that affect chain and community pharmacies. Most importantly, it is...
California Assembly Bill 1286, the Stop Dangerous Pharmacist Act, was passed in late 2023 and took effect at the start of this year. The bill makes some significant changes that affect chain and community pharmacies. Most importantly, it is...
California Assembly Bill 1286,...
03/07/2024
Pharmacy Learning Network

Advertisement

Douglass Jennings
Talking Therapeutics
Signal for Cardiovascular Harm With Triple Inhaler Therapy
03/01/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this installment of Talking Therapeutics, Dr Jennings reviews cardiovascular harm with triple inhaler therapy for patients with chronic obstructive pulmonary disorder (COPD).
In this installment of Talking Therapeutics, Dr Jennings reviews cardiovascular harm with triple inhaler therapy for patients with chronic obstructive pulmonary disorder (COPD).
In this installment of Talking...
03/01/2024
Pharmacy Learning Network
Commentary
Investigating the Increased Adoption of Weight Loss Drugs: Ensuring Safe and Effective Use
03/01/2024
Yvette C Terrie, BS Pharm, RPh, consultant pharmacist
The surge in obesity, compounded by COVID-19, has led to increased use of weight loss drugs, notably semaglutide (Wegovy) and tirzepatide (Zepbound) gaining FDA approval. Concerns over adverse effects like pancreatitis and gastroparesis with...
The surge in obesity, compounded by COVID-19, has led to increased use of weight loss drugs, notably semaglutide (Wegovy) and tirzepatide (Zepbound) gaining FDA approval. Concerns over adverse effects like pancreatitis and gastroparesis with...
The surge in obesity, compounded...
03/01/2024
Pharmacy Learning Network

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use